Citigroup initiated coverage on Alnylam Pharma with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for ALNY
Across the 24 sessions after earlier ALNY headlines, the stock closed higher 9 times and lower 15 times, with a median move of 1.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ALNY | SPY |
|---|---|---|---|
| May 12, 2026 | New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden | +2.5% | -0.2% |
| May 7, 2026 | Alnylam to Webcast Presentations at Upcoming Investor Conferences | -2.3% | -0.3% |
| May 4, 2026 | Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM | +0.6% | -0.4% |
| Apr 30, 2026 | Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress | +2.8% | +1.0% |
| Apr 16, 2026 | Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results | -4.0% | +0.2% |
| Mar 30, 2026 | New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management | -0.4% | -0.3% |
Keep researching ALNY
- What is Initiation of coverage?The first research report an analyst or brokerage publishes on a company, setting an opening rating and price target.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- ALNY insider tradesEvery buy and sale reported by Alnylam Pharmaceuticals Inc. officers, directors and large holders.
- ALNY earnings historyPast Alnylam Pharmaceuticals Inc. earnings releases, newest first.
- ALNY financial statementsRevenue, profit, cash flow and balance sheet from Alnylam Pharmaceuticals Inc.'s SEC filings.
Quantisnow market dataNASDAQ
ALNY
Alnylam Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2004
Get push alerts for ALNY
Full ALNY profile on Quantisnow Follow ALNY and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time